GI & Endoscopy

The Colorectal Cancer Alliance is providing four researchers a combined $625,000 in grants to fund CRC research.

From its potential for growth to colorectal cancer screening trends, here are five things for ASCs to know about GI:

Here are five updates from gastroenterology companies and industry-relevant companies to note:

Isaac Raijman, MD, is the gastroenterology chief at Houston-based CHI Baylor St. Luke's Hospital.

Optical biopsy firm Mauna Kea Technologies reported drastic year-over-year sales growth in the fourth quarter of 2018, after transitioning to a pay-per-use business model.

Wolters Kluwer will handle publishing duties for The American College of Gastroenterology's three academic journals.

Corporate Knights included Takeda as one of the 2019 Global 100 Most Sustainable Corporations in the World, noting it was in the top 1.3 percent of corporate sustainability performers in the world.

A study published in Gastrointestinal Endoscopy compared direct screening colonoscopy to fecal immunochemical-positive colonoscopy to justify differential targets in the Asia-Pacific region.

The FDA awarded DNA testing company 23andMe clearance to include risk reports associated with hereditary colorectal cancer in its testing suite.

Brian P. Bosworth, MD, is the chief of medicine at New York City-based NYU Langone Health's Tisch Hospital.